Industry Verticals »

All Categories

Insights »

About TMR »

Collagen and HA-based Biomaterials Market

Collagen and HA-based Biomaterials Market (Type: Urinary Incontinence, Corneal Shields, Facial Aesthetic Dermal Fillers, Wound Dressings, and Others; Application: Food, Medicine, Cosmetics, and Others) – Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019 - 2027

Collagen and HA-based Biomaterials Market – Need for Enhancing Patient Outcomes Driving Engine for Innovation 

Facial aesthetic treatments, in recent years, have been focused on high quality results with minimal steps involved. And while for years, collagen and hyaluronic acid (HA)-based biomaterials have been used for improving would healing and cosmetic surgeries, currently, there has been a flurry of activity, all aimed at enhancing patient outcomes. These innovations include several advanced dermal fillers that have been developed to cater to the skincare needs of people, globally. For instance, in May 2018, Nestlé Skin Health’s dermal filler Restylane® Lyft was approved by the Food and Drug Association for aesthetic and cosmetic purposes. According to this recent study by Transparency Market Research (TMR), the collagen and HA-based biomaterials market is set to grow at an average CAGR of ~5% during the forecast period of 2019 to 2027. The study projects a rise in investments toward research & development (R&D) that are predominantly aimed at discovering collagen and HA-based biomaterials that can be used in next-generation, innovative products such as injectable dermal fillers, in various cosmetic surgeries.

collagen ha based biomaterials market infographic

Adoption of Collagen and HA-based Biomaterials to Grow Beyond Cosmetic Surgeries 

There has been a rise in the number of cosmetic surgeries around the globe, in recent years, due to technological advancements and the launching of new & effective products. Nevertheless, collagen and hyaluronic acid-based biomaterials are also being increasingly used in the treatment of chronic diseases such as diabetes, degenerative joint disorders, and skin infections, which is also a major driver of the global collagen and HA-based biomaterials market. 

The advantages that are offered by collagen include stability, even as it stimulates tissue growth, which is being leveraged by manufacturers to provide better treatment options for orthopaedic care and wound care. Manufacturers are also increasingly focusing on the medical needs of patients with joint- and mobility-related issues, the increasing prevalence of which is likely to cause significant economic burden, globally.

According to this study on the global collagen and HA-based biomaterials market, the adoption of collagen for wound dressings is contributing to the healthy growth of its application in medicine, which is estimated to capture around one-fourth of the total share of the global collagen and hyaluronic acid-based biomaterials market by 2027. The study also finds that, in 2018, facial aesthetic dermal fillers occupied the largest share by way of revenue in the global collagen and HA-based biomaterials market, and this is likely to continue over the forecast period. This can be attributed to the demand for HA-based dermal fillers for the improvement of facial aesthetics, as well as in applications beyond cosmetic surgeries. 

Demand for Animal-derived Collagen to Decline Due to Religious Concerns 

With animal-derived constituents progressively becoming a part of healthcare, especially in the case of collagen sources, religious and cultural beliefs are increasingly hampering the acceptance and adoption of collagen and hyaluronic acid-based biomaterials. Pigs and cows are a rich source of collagen, and the usage of products derived from these sources is problematic in different regional markets, as such, negatively impacting the growth of the global collagen and HA-based biomaterials market.

collagen ha based biomaterials market segmentation

Analysts’ Viewpoint 

Authors of this report estimate that, the collagen and HA-based biomaterials market will grow at an average pace during the forecast years. This is expected to come on the back of the rising popularity of cosmetic surgeries, with players in the market competing aggressively in the global landscape with new product launches and innovations. Stakeholders should focus on R&D into alternatives to animal-derived constituents, from synthetic sources, to boost their popularity, and therefore, the adoption of collagen and HA-based biomaterials in cosmetics and healthcare. 

Of the regional markets in the global collagen and HA-based biomaterials market, North America is expected to continue to hold the largest share by revenue, due to better healthcare facilities in the region. However, the market in Asia Pacific is also brimming with opportunities for manufacturers to capitalise on, as the region witnesses an increased geriatric population suffering from degenerative joint disorders.

Global Collagen and HA-based Biomaterials Market: Introduction

  • Collagen is one of the most abundant form of protein in the human body, and the use of this biomaterial in tissue engineering has increased extensively, owing to its easy availability, biodegradability, versatility, and biocompatibility.
  • The application of exogenous hyaluronan and hyaluronan-based biomaterials has been successful in wound healing, cosmetic surgeries, food packing & ingredients, and a number of other medical disciplines such as dermatology, rheumatology, and ophthalmology
  • Rise in cosmetic procedures across the globe, technological advancements, launch of new collagen-based products in developed regions, increase in the prevalence of joint disorders worldwide, and advantages offered by HA-based biomaterials are anticipated to drive the global collagen and HA-based biomaterials market during the forecast period.
  • The global collagen and HA-based biomaterials market was valued at ~US$ 6 Bn in the years 2018, and is anticipated to reach a value of ~US$ 9.7 Bn by 2027, expanding at a CAGR of ~5% from 2019 to 2027.
  • North America, Europe, and Asia Pacific were the major markets for collagen and HA-based biomaterials in 2018. The collagen and HA-based biomaterials market in Asia Pacific is expected to expand at a high CAGR of ~6% during the forecast period.

Collagen and HA-based Biomaterials Market: Overview

  • Biomaterials are one of the most vital materials used in healthcare and pharmaceutical industries. Collagen and HA-based biomaterials are widely used in tissue engineering due to their wide availability, biodegradability, and biocompatibility. Collagen and HA-based biomaterials have potential application in the fields of regenerative medicine, food industry, personal healthcare, and development of prosthetics.
  • Rapid technological advancements, significant new product launches by industry players, surge in cosmetic procedures, and advantages offered by collagen and HA-based biomaterials are likely to fuel the growth of the global collagen and HA-based biomaterials market during the forecast period.
  • North America held a major share of the global collagen and HA-based biomaterials market in 2018, due to the wide acceptance and availability of collagen and HA-based biomaterials, and rise in hyaluronic acid dermal filler procedures performed in the U.S.
  • The collagen and HA-based biomaterials market in Asia Pacific is expected to expand at a CAGR of ~6% from 2019 to 2027, due to an increase in the usage of collagen-enriched face masks, HA-based dermal fillers, and other cosmetic products.

Collagen and HA-based Biomaterials Market: Key Segments

  • In terms of type, the global collagen and HA-based biomaterials market has been segmented into urinary incontinence, corneal shields, facial aesthetic dermal fillers, wound dressings, and others The facial aesthetic dermal fillers segment accounted for a major share of the collagen and HA-based biomaterials market in 2018, and the trend is anticipated to continue during the forecast period.
  • Based on application, the global collagen and HA-based biomaterials market has been categorized into food, medicine, cosmetics, and others. The cosmetics segment accounted for a major share of the market in 2018. 

Collagen and HA-based Biomaterials Market: Prominent Companies

  • Key players in the global collagen and HA-based biomaterials market have been profiled based on attributes, such as company overview, product portfolio, financial overview, recent developments, and competitive business strategies.
  • Major companies profiled in the global collagen and HA-based biomaterials market report are
    • Galderma Laboratories L.P. (Nestle Skin Health)
    • Allergan plc
    • Collagen Solutions Plc
    • Anika Therapeutics, Inc.
    • Johnson & Johnson Services, Inc.
    • Sanofi
    • Bausch Health Companies Inc.
    • BioCell Technology LLC
    • Abbott Laboratories. 

North America to Dominate Global Market; Asia Pacific to Offer Growth Opportunities

  • In terms of region, the global collagen and HA-based biomaterials market has been segmented into North America, Europe, Latin America, Asia Pacific, and the Middle East & Africa. North America is projected to account for a leading share of the global collagen and HA-based biomaterials market during the forecast period.
  • Early adoption and growing popularity of bovine and HA-based fillers in the U.S. and Canada, and rapid increase in market penetration of new players with novel collagen and HA-based biomaterials are estimated to drive the collagen and HA-based biomaterials market in North America.
  • The collagen and HA-based biomaterials market in Asia Pacific is projected to grow at a rapid pace during the forecast period. India and China are anticipated to be lucrative markets for collagen and HA-based biomaterials during the forecast period. This can be attributed to the increase in the burden of joint disorders such as knee osteoarthritis, as well as chronic diseases such as diabetes, in these countries.
  • Increase in cosmetic procedures in Japan is projected to boost the collagen and HA-based biomaterials market in Asia Pacific during the forecast period.

Frequently Asked Questions

What is the total market worth of collagen and HA-based biomaterials market?

Collagen and HA-based biomaterials market is anticipated to reach a value of ~US$ 9.7 Bn by 2027

What is the anticipated CAGR of the collagen and HA-based biomaterials market in the forecast period?

Collagen and HA-based biomaterials market to expand at a CAGR of ~5% from 2019 to 2027

What are the key driving factors for the growth of the collagen and HA-based biomaterials market?

Collagen and HA-based biomaterials market is driven by rise in cosmetic procedures across the globe.

Which is the rising prominent segment in the collagen and HA-based biomaterials market?

The facial aesthetic dermal fillers segment dominated the global collagen and HA-based biomaterials market, and the trend is anticipated to continue during the forecast period.

Who are the key players in the collagen and HA-based biomaterials market?

Key players in the global collagen and HA-based biomaterials market include Galderma Laboratories L.P. (Nestle Skin Health), Allergan plc, Collagen Solutions Plc, Anika Therapeutics, Inc., Johnson & Johnson Services, Inc.

1. Preface 

    1.1. Market Definition and Scope

    1.2. Market Segmentation

    1.3. Key Research Objectives

    1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Collagen and HA-based Biomaterials Market

4. Market Overview

    4.1. Introduction

    4.2. Overview

    4.3. Market Dynamics

        4.3.1. Drivers

        4.3.2. Restraints

        4.3.3. Opportunities

    4.4. Global Collagen and HA-based Biomaterials Market Analysis and Forecast, 2017–2027

        4.4.1. Market Revenue Projections (US$ Mn)

    4.5. Porter’s Five Force Analysis

5. Market Outlook

    5.1. Key Industry Developments 

    5.2. Major Research Institutes Involved 

    5.3. Technological Advancements

    5.4. Key Mergers & Acquisitions

    5.5. Pricing Analysis

6. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Type 

    6.1. Introduction & Definition 

    6.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn)Forecast, by Type, 2017–2027

        6.2.1. Urinary Incontinence

        6.2.2. Corneal Shields

        6.2.3. Facial Aesthetic Dermal Fillers

        6.2.4. Wound Dressings

        6.2.5. Others

    6.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Type

7. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Application 

    7.1. Introduction 

    7.2. Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

        7.2.1. Food

        7.2.2. Medicine

        7.2.3. Cosmetics

        7.2.4. Others

    7.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Application

8. Global Collagen and HA-based Biomaterials Market Value and Forecast, by Region

    8.1. Introduction 

    8.2. Collagen and HA-based biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027

        8.2.1. North America

        8.2.2. Europe

        8.2.3. Asia Pacific

        8.2.4. Latin America

        8.2.5. Middle East & Africa  

    8.3. Global Collagen and HA-based Biomaterials Market Attractiveness, by Region

9. North America Collagen and HA-based Biomaterials Market Analysis and Forecast 

    9.1. Introduction

    9.2. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

        9.2.1. Urinary Incontinence

        9.2.2. Corneal Shields

        9.2.3. Facial Aesthetic Dermal Fillers

        9.2.4. Wound Dressings

        9.2.5. Others

    9.3. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

        9.3.1. Food

        9.3.2. Medicine

        9.3.3. Cosmetics

        9.3.4. Others

    9.4. North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        9.4.1. U.S.

        9.4.2. Canada

    9.5. North America Collagen and HA-based Biomaterials Market Attractiveness Analysis

        9.5.1. By Type

        9.5.2. By Application 

        9.5.3. By Country/Sub-region

10. Europe Collagen and HA-based Biomaterials Market Analysis and Forecast 

    10.1. Introduction

    10.2. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

        10.2.1. Urinary Incontinence

        10.2.2. Corneal Shields

        10.2.3. Facial Aesthetic Dermal Fillers

        10.2.4. Wound Dressings

        10.2.5. Others

    10.3. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

        10.3.1. Food

        10.3.2. Medicine

        10.3.3. Cosmetics

        10.3.4. Others

    10.4. Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        10.4.1. Germany

        10.4.2. U.K.

        10.4.3. France

        10.4.4. Spain

        10.4.5. Italy 

        10.4.6. Rest of Europe

    10.5. Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis

        10.5.1. By Type

        10.5.2. By Application 

        10.5.3. By Country/Sub-region

11. Asia Pacific Collagen and HA-based Biomaterials Market Analysis and Forecast 

    11.1. Introduction

    11.2. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

        11.2.1. Urinary Incontinence

        11.2.2. Corneal Shields

        11.2.3. Facial Aesthetic Dermal Fillers

        11.2.4. Wound Dressings

        11.2.5. Others

    11.3. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

        11.3.1. Food

        11.3.2. Medicine

        11.3.3. Cosmetics

        11.3.4. Others

    11.4. Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        11.4.1. Japan

        11.4.2. China

        11.4.3. India

        11.4.4. Australia & New Zealand

        11.4.5. Rest of Asia Pacific

    11.5. Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis

        11.5.1. By Type

        11.5.2. By Application 

        11.5.3. By Country/Sub-region

12. Latin America  Collagen and HA-based biomaterials Market Analysis and Forecast 

    12.1. Introduction

    12.2. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

        12.2.1. Urinary Incontinence

        12.2.2. Corneal Shields

        12.2.3. Facial Aesthetic Dermal Fillers

        12.2.4. Wound Dressings

        12.2.5. Others

    12.3. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

        12.3.1. Food

        12.3.2. Medicine

        12.3.3. Cosmetics

        12.3.4. Others

    12.4. Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        12.4.1. Brazil

        12.4.2. Mexico

        12.4.3. Rest of Latin America

    12.5. Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis

        12.5.1. By Type

        12.5.2. By Application 

        12.5.3. By Country/Sub-region

13. Middle East & Africa  Collagen and HA-based biomaterials Market Analysis and Forecast 

    13.1. Introduction

    13.2. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

        13.2.1. Urinary Incontinence

        13.2.2. Corneal Shields

        13.2.3. Facial Aesthetic Dermal Fillers

        13.2.4. Wound Dressings

        13.2.5. Others

    13.3. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

        13.3.1. Food

        13.3.2. Medicine

        13.3.3. Cosmetics

        13.3.4. Others

    13.4. Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

        13.4.1. GCC Countries

        13.4.2. South Africa

        13.4.3. Rest of Middle East & Africa

    13.5. Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis

        13.5.1. By Type

        13.5.2. By Application 

        13.5.3. By Country/Sub-region

14. Competition Landscape

    14.1. Market Player – Competition Matrix (By Tier and Size of companies)

    14.2. Global Collagen and HA-based Biomaterials Market Share Analysis, by Company (2018)

    14.3. Company Profiles

        14.3.1. Collagen Solutions Plc

            14.3.1.1. Company Description

            14.3.1.2. Business Overview

            14.3.1.3. Financial Overview

            14.3.1.4. Strategic Overview

            14.3.1.5. SWOT Analysis

        14.3.2. Sanofi

            14.3.2.1. Company Description

            14.3.2.2. Business Overview

            14.3.2.3. Financial Overview

            14.3.2.4. Strategic Overview

            14.3.2.5. SWOT Analysis

        14.3.3. Allergan plc 

            14.3.3.1. Company Description

            14.3.3.2. Business Overview

            14.3.3.3. Financial Overview

            14.3.3.4. Strategic Overview

            14.3.3.5. SWOT Analysis

        14.3.4. Anika Therapeutics, Inc.

            14.3.4.1. Company Description

            14.3.4.2. Business Overview

            14.3.4.3. Financial Overview

            14.3.4.4. Strategic Overview

            14.3.4.5. SWOT Analysis

        14.3.5. Bausch Health Companies Inc.

            14.3.5.1. Company Description

            14.3.5.2. Business Overview

            14.3.5.3. Financial Overview

            14.3.5.4. Strategic Overview

            14.3.5.5. SWOT Analysis

        14.3.6. Abbott Laboratories

            14.3.6.1. Company Description

            14.3.6.2. Business Overview

            14.3.6.3. Financial Overview

            14.3.6.4. Strategic Overview

            14.3.6.5. SWOT Analysis

        14.3.7. Johnson & Johnson Services, Inc.

            14.3.7.1. Company Description

            14.3.7.2. Business Overview

            14.3.7.3. Financial Overview

            14.3.7.4. Strategic Overview

            14.3.7.5. SWOT Analysis

        14.3.8. Galderma Laboratories L.P. (Nestle Skin Health) 

            14.3.8.1. Company Description

            14.3.8.2. Business Overview

            14.3.8.3. Financial Overview

            14.3.8.4. Strategic Overview

            14.3.8.5. SWOT Analysis

        14.3.9. BioCell Technology LLC 

            14.3.9.1. Company Description

            14.3.9.2. Business Overview

            14.3.9.3. Financial Overview

            14.3.9.4. Strategic Overview

            14.3.9.5. SWOT Analysis

List of Tables

Table 01: List of Research Institutes

Table 02: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 03: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017–2027

Table 04: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Region, 2017–2027

Table 05: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 06: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 07: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

Table 08: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region,

Table 09: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 10: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

Table 11: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 12: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 13: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

Table 14: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027

Table 15: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type, 2017–2027

Table 16: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

Table 17: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by

Table 18: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Type,

Table 19: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, by Application, 2017?2027

List of Figures

Figure 01: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) and Distribution (%), by Region, 2019 and 2027

Figure 02: Global Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast, 2017–2027

Figure 03: Global Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018

Figure 04: Global Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018

Figure 05: Global Collagen and HA-based Biomaterials Market Value Share (%), by Region, 2018

Figure 07: Evolution of Dermal Fillers

Figure 08: Technological Advances – Dermal Fillers

Figure 09: Key Mergers & Acquisitions

Figure 10: Global Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

Figure 11: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Urinary Incontinence, 2017–2027

Figure 12: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Corneal Shields, 2017–2027

Figure 13: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Facial Aesthetic Dermal Fillers, 2017–2027

Figure 14: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Wound Dressings, 2017–2027

Figure 15: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 16: Global Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

Figure 17: Global Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

Figure 18: Global Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

Figure 19: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Food, 2017–2027

Figure 20: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medicine, 2017–2027

Figure 21: Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Cosmetics, 2017–2027

Figure 22 Global Collagen and HA-based Biomaterials Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027

Figure 23: Global Collagen and HA-based Biomaterials Market Value Share Analysis, by Region, 2018 and 2027

Figure 24: Global Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Region, 2019–2027

Figure 25: North America Collagen and HA-based Biomaterials Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027

Figure 26: North America Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 27: North America Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 28: North America Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

Figure 29: North America Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

Figure 30: North America Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

Figure 31: North America Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

Figure 32: Europe Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 33: Europe Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 34: Europe Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 35: Europe Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

Figure 36: Europe Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

Figure 37: Europe Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

Figure 38: Europe Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

Figure 39: Asia Pacific Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 40: Asia Pacific Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region, 2018 and 2027

Figure 41: Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 42: Asia Pacific Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

Figure 43: Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

Figure 44: Asia Pacific Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

Figure 45: Asia Pacific Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

Figure 46: Latin America Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 47: Latin America Collagen and HA-based Biomaterials Market Value Share Analysis, by Country/Sub-region,

Figure 48: Latin America Collagen and HA-based Biomaterials Market Attractiveness Analysis, by Country/Sub-region, 2019–2027

Figure 49: Latin America Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

Figure 50: Latin America Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

Figure 51: Latin America Collagen and HA-based Biomaterials Market Value Share (%), by Application, 2018 and 2027

Figure 52: Latin America Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

Figure 53: Middle East & Africa Collagen and HA-based Biomaterials Market Value (US$ Mn) and Y-o-Y Growth (%) Forecast, 2017–2027

Figure 54: Middle East & Africa Collagen and HA-based Biomaterials Market Value Share Analysis, by

Figure 55: Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness Analysis, by

Figure 56: Middle East & Africa Collagen and HA-based Biomaterials Market Value Share (%), by Type, 2018 and 2027

Figure 57: Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness, by Type, 2019–2027

Figure 58: Middle East & Africa Collagen and HA-based Biomaterials Market Value Share (%), by Application,

Figure 59: Middle East & Africa Collagen and HA-based Biomaterials Market Attractiveness, by Application, 2019–2027

Figure 60: Global Collagen and HA-based Biomaterials Market Share, by Company, 2018

Figure 61: Collagen Solutions Plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 62: Collagen Solutions Plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 63: Collagen Solutions Plc, Breakdown of Net Sales (%), by Region, 2018

Figure 64: Sanofi, Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 65: Sanofi, Breakdown of Net Sales (%), by Business Segment, 2018

Figure 66: Sanofi, Breakdown of Net Sales (%), by Geography, 2018

Figure 67: Sanofi, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 68: Allergan plc, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 69: Allergan plc, R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 70: Allergan plc, Breakdown of Net Sales (%), by Product & Region, 2018

Figure 71: Anika Therapeutics, Inc., Revenue (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 72: Anika Therapeutics, Inc., Breakdown of Net Sales (%), by Business Segment, 2018

Figure 73: Anika Therapeutics, Inc., Breakdown of Net Sales (%), by Geography, 2018

Figure 74: Anika Therapeutics, Inc., R&D Expenses (US$ Mn) & Y-o-Y Growth (%), 2015–2018

Figure 75: Bausch Health Companies Inc. Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 76: Bausch Health Companies Inc. R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2014–2017

Figure 77: Bausch Health Companies Inc., Breakdown of Net Sales, by Region, 2017

Figure 78: Bausch Health Companies Inc., Breakdown of Net Sales, by Business Segment, 2017

Figure 79: Abbott Laboratories, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 80: Abbott Laboratories, R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 81: Abbott Laboratories, Breakdown of Net Sales, by Region, 2017

Figure 82: Abbott Laboratories, Breakdown of Net Sales, by Business Segment, 2018

Figure 83: Johnson & Johnson, Revenue (US$ Mn) and Y-o-Y Growth (%), 2015–2018

Figure 84: Johnson & Johnson Breakdown of Net Sales (%), by Business Segment, 2018

Figure 85: Johnson & Johnson, Breakdown of Net Sales (%), by Region, 2018

Figure 86: Johnson and Johnson R&D Expenses (US$ Mn) and Y-o-Y Growth (%), 2015–2018 

Copyright © Transparency Market Research, Inc. All Rights reserved

Collagen and HA-based Biomaterials Market

Schedule a Call